PerkinElmer Inc
LSE:0KHE
Operating Margin
PerkinElmer Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD |
15%
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
152.4B USD |
18%
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
136.3B USD |
22%
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
73.4T KRW |
32%
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
39.2B CHF |
18%
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.3B USD |
24%
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
186.9B CNY |
27%
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.4B USD |
29%
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
24.6B USD |
15%
|
|
| US |
|
Waters Corp
NYSE:WAT
|
21.1B USD |
28%
|
|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
18.8B EUR |
14%
|
PerkinElmer Inc
Glance View
PerkinElmer Inc., originally founded in 1937, has evolved over the decades into a leading global innovator in the field of healthcare and life sciences. It began its journey by focusing on precision optics, but with time, the company strategically pivoted towards life sciences, diagnostics, and applied markets. This transformation harnessed its focus on innovative technologies that aid in the process of scientific discovery and clinical diagnostics. PerkinElmer primarily thrives on providing advanced solutions for detecting and analyzing biological and chemical compounds. With its robust portfolio of products and services, the company empowers laboratories and research institutions worldwide to unlock new insights into areas such as genetics, oncology, and environmental health. The company's revenue streams are multifaceted, embodying a mix of instruments, software, and services that cater to a variety of needs in the scientific and healthcare communities. PerkinElmer’s business model is anchored on selling sophisticated laboratory equipment like mass spectrometers, imaging systems, and diagnostic testing kits. Beyond equipment sales, the company also capitalizes on recurring revenue from consumables and services, ensuring a steady cash flow that supports its ongoing R&D efforts and market expansion initiatives. Furthermore, with a strategic emphasis on bolstering partnerships and acquisitions, PerkinElmer continually enhances its capability to deliver comprehensive solutions, thus maintaining its competitive edge in the ever-evolving scientific landscape. Through this, it manages to contribute not just to profitability but to a broader mission of improving global health outcomes.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on PerkinElmer Inc's most recent financial statements, the company has Operating Margin of 14.5%.
You don't have any saved screeners yet